408 related articles for article (PubMed ID: 31724735)
1. Suppression of autoreactive T and B lymphocytes by anti-annexin A1 antibody in a humanized NSG murine model of systemic lupus erythematosus.
Mihaylova N; Chipinski P; Bradyanova S; Velikova T; Ivanova-Todorova E; Chausheva S; Herbáth M; Kalinova D; Prechl J; Kyurkchiev D; Tchorbanov AI
Clin Exp Immunol; 2020 Mar; 199(3):278-293. PubMed ID: 31724735
[TBL] [Abstract][Full Text] [Related]
2. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus.
Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI
Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody therapy that targets phospholipid-binding protein delays lupus activity in MRL/lpr mice.
Mihaylova N; Bradyanova S; Chipinski P; Chausheva S; Kyurkchiev D; Tchorbanov AI
Scand J Immunol; 2020 Sep; 92(3):e12915. PubMed ID: 32533866
[TBL] [Abstract][Full Text] [Related]
4. Anti-ANX A1 Antibody Therapy in MRL/lpr Murine Model of Systemic Lupus Erythematosus.
Bradyanova S; Mihaylova N; Chipinski P; Manassiev Y; Herbáth M; Kyurkchiev D; Prechl J; Tchorbanov AI
Arch Immunol Ther Exp (Warsz); 2021 Jul; 69(1):19. PubMed ID: 34322760
[TBL] [Abstract][Full Text] [Related]
5. Suppression of dsDNA-specific B lymphocytes reduces disease symptoms in SCID model of mouse lupus.
Gesheva V; Kerekov N; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Autoimmunity; 2014 May; 47(3):162-72. PubMed ID: 24502777
[TBL] [Abstract][Full Text] [Related]
6. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
Liu L; Takeda K; Akkoyunlu M
Front Immunol; 2020; 11():1569. PubMed ID: 32849532
[TBL] [Abstract][Full Text] [Related]
7. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():662901. PubMed ID: 34093553
[TBL] [Abstract][Full Text] [Related]
8. Elimination of autoreactive B cells in humanized SCID mouse model of SLE.
Kerekov NS; Mihaylova NM; Grozdev I; Todorov TA; Nikolova M; Baleva M; Nikolova M; Prechl J; Erdei A; Tchorbanov AI
Eur J Immunol; 2011 Nov; 41(11):3301-11. PubMed ID: 21830207
[TBL] [Abstract][Full Text] [Related]
9. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
[TBL] [Abstract][Full Text] [Related]
10. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic cord blood regulatory T cells decrease dsDNA antibody and improve albuminuria in systemic lupus erythematosus.
Lyu MA; Tang X; Khoury JD; Raso MG; Huang M; Zeng K; Nishimoto M; Ma H; Sadeghi T; Flowers CR; Parmar S
Front Immunol; 2023; 14():1217121. PubMed ID: 37736101
[TBL] [Abstract][Full Text] [Related]
12. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
13. Long-term B cell depletion in murine lupus eliminates autoantibody-secreting cells and is associated with alterations in the kidney plasma cell niche.
Wang W; Rangel-Moreno J; Owen T; Barnard J; Nevarez S; Ichikawa HT; Anolik JH
J Immunol; 2014 Apr; 192(7):3011-20. PubMed ID: 24574498
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells.
Nagafuchi H; Wakisaka S; Takeba Y; Takeno M; Sakane T; Suzuki N
Clin Exp Rheumatol; 2002; 20(5):625-31. PubMed ID: 12412192
[TBL] [Abstract][Full Text] [Related]
15. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
16. Autoreactive T cells from MRL-lpr/lpr mice secrete multiple lymphokines and induce the production of IgG anti-DNA antibodies.
Deusch K; Fernandez-Botran R; Konstadoulakis M; Baur K; Schwartz RS; Madaio MP
J Autoimmun; 1991 Aug; 4(4):563-76. PubMed ID: 1777009
[TBL] [Abstract][Full Text] [Related]
17. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
18. A peptide derived from an autoantibody can stimulate T cells in the (NZB x NZW)F1 mouse model of systemic lupus erythematosus.
Ebling FM; Tsao BP; Singh RR; Sercarz E; Hahn BH
Arthritis Rheum; 1993 Mar; 36(3):355-64. PubMed ID: 7680861
[TBL] [Abstract][Full Text] [Related]
19. Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice.
Chae BS; Shin TY
Arch Pharm Res; 2007 Feb; 30(2):191-8. PubMed ID: 17366741
[TBL] [Abstract][Full Text] [Related]
20. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.
Herber D; Brown TP; Liang S; Young DA; Collins M; Dunussi-Joannopoulos K
J Immunol; 2007 Mar; 178(6):3822-30. PubMed ID: 17339481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]